All In Biotech

Free tool

FAERS Monitor: Colestid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020222 or its brand name (Colestid, Colestipol Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,659

Serious

1,527

57% of reports

Hospitalization

667

Death reported

115

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea380
  • off label use288
  • nausea233
  • fatigue220
  • drug ineffective181
  • headache145
  • vomiting128
  • pain127
  • weight decreased116
  • arthralgia115
  • asthenia115
  • dizziness112
  • dyspnoea110
  • crohn^s disease106
  • malaise102

Reports by year received

View as table
YearReports
200425
200532
200624
200735
200840
200968
2010100
2011102
2012130
201356
201453
201586
2016113
2017123
2018155
2019150
2020128
2021163
2022213
2023210
2024236
2025245
2026172

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,500 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
diarrhoeaSignal3804.74.21,122
weight decreasedSignal1163.32.8185
off label useSignal2882.62.3295
astheniaSignal1152.42.096
nauseaSignal2332.32.1182
fatigueSignal2202.22.0155
arthralgiaSignal1152.21.874
vomitingSignal1282.21.880
malaise1021.81.539
headache1451.81.655
dizziness1121.81.538
pain1271.61.432
dyspnoea1101.51.321
drug ineffective1811.10.91
crohn^s disease1060.00.0831,315

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.